Article
CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation.
Journal of immunology (Baltimore, Md. : 1950) - 1 Mar 1998
Céfaï D, Schneider H, Matangkasombut O, Kang H, Brody J, Rudd C E
Abstract excerpt
Although the lipid kinase phosphatidylinositol 3-kinase (PI-3K) binds at high levels to the cytoplasmic tail of CD28, controversy exists regarding its role in CD28 costimulation. Potentially, the kinase could be linked to a signaling cascade or be needed indirectly in events such as receptor endocytosis. Indeed, little is known regarding both the fate of CD28 following receptor ligation and the events that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
